Inhibrx Biosciences Ownership 2024 | Who Owns Inhibrx Biosciences Now?
Institutional Ownership
0.05%
Insider Ownership
23.55%
Retail Ownership
76.41%
Institutional Holders
1.00
Inhibrx Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEKABANK DEUTSCHE GIROZENTRALE | 0.05% | 0.00% | 26,400 | - | - | 928,000 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.01% | 0.00% | 6,690 | -537 | -7.43% | 228,188 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -16,926 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -72,764 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -496 | -100.00% | - | Jun 30, 2024 |
| M&T BANK CORP | - | - | - | -21,476 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -741,591 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -14,486 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -307,541 | -100.00% | - | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -14,812 | -100.00% | - | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | - | -5 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -2,417,584 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -1,861,469 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -282,303 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -1,759 | -100.00% | - | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -31 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,950 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -20,765 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -13,882 | -100.00% | - | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -18,866 | -100.00% | - | Jun 30, 2024 |
Inhibrx Biosciences's largest institutional shareholder is DEKABANK DEUTSCHE GIROZENTRALE, holding 0.05% of the company's total share outstanding, currently valued at $928.00K. The top 10 institutional shareholders own together 0.06% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEKABANK DEUTSCHE GIROZENTRALE | 0.05% | 0.00% | 26,400 | - | - | 928,000 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.01% | 0.00% | 6,690 | -537 | -7.43% | 228,188 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -16,926 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -72,764 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -496 | -100.00% | - | Jun 30, 2024 |
| M&T BANK CORP | - | - | - | -21,476 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -741,591 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -14,486 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -307,541 | -100.00% | - | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -14,812 | -100.00% | - | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | - | -5 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -2,417,584 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -1,861,469 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -282,303 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -1,759 | -100.00% | - | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -31 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,950 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -20,765 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -13,882 | -100.00% | - | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -18,866 | -100.00% | - | Jun 30, 2024 |
The largest Inhibrx Biosciences shareholder by % of total assets is DEKABANK DEUTSCHE GIROZENTRALE. The company owns 26.40K shares of Inhibrx Biosciences (INBX), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEKABANK DEUTSCHE GIROZENTRALE | 0.05% | 0.00% | 26,400 | - | - | 928,000 | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -2 | -100.00% | - | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | - | -5 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -8 | -100.00% | - | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | - | - | - | -13 | -100.00% | - | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | - | -25 | -100.00% | - | Jun 30, 2024 |
| GAMMA INVESTING LLC | - | - | - | -31 | -100.00% | - | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -31 | -100.00% | - | Jun 30, 2024 |
| LINDBROOK CAPITAL, LLC | - | - | - | -69 | -100.00% | - | Jun 30, 2024 |
| DAIWA SECURITIES GROUP INC. | - | - | - | -175 | -100.00% | - | Jun 30, 2024 |
| QUARRY LP | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -398 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -496 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.01% | 0.00% | 6,690 | -537 | -7.43% | 228,188 | Jun 30, 2024 |
| QUADRANT CAPITAL GROUP LLC | - | - | - | -690 | -100.00% | - | Jun 30, 2024 |
| SIGNATUREFD, LLC | - | - | - | -758 | -100.00% | - | Jun 30, 2024 |
| PACER ADVISORS, INC. | - | - | - | -942 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -1,176 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -1,215 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -1,324 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Inhibrx Biosciences's largest institutional buyer is DEKABANK DEUTSCHE GIROZENTRALE. The company purchased 0.00 stocks of INBX, valued at $928.00K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | - | - | - | -7,150,826 | -100.00% | - | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | - | - | - | -4,256,104 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -2,751,705 | -100.00% | - | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -2,629,837 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -2,417,584 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -1,861,469 | -100.00% | - | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | - | - | - | -1,750,387 | -100.00% | - | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | - | - | - | -1,302,645 | -100.00% | - | Jun 30, 2024 |
| ALPINE ASSOCIATES MANAGEMENT INC. | - | - | - | -1,054,475 | -100.00% | - | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | - | - | - | -891,220 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -800,000 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -741,591 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -704,825 | -100.00% | - | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -700,000 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -549,469 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -542,971 | -100.00% | - | Jun 30, 2024 |
| MMCAP INTERNATIONAL INC. SPC | - | - | - | -451,433 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -445,197 | -100.00% | - | Jun 30, 2024 |
| SLOTNIK CAPITAL, LLC | - | - | - | -419,778 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -376,540 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Inhibrx Biosciences's biggest institutional seller is VIKING GLOBAL INVESTORS LP. The company sold -7.15M shares of INBX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | - | - | - | -7,150,826 | -100.00% | - | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | - | - | - | -4,256,104 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -2,751,705 | -100.00% | - | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -2,629,837 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -2,417,584 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -1,861,469 | -100.00% | - | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | - | - | - | -1,750,387 | -100.00% | - | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | - | - | - | -1,302,645 | -100.00% | - | Jun 30, 2024 |
| ALPINE ASSOCIATES MANAGEMENT INC. | - | - | - | -1,054,475 | -100.00% | - | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | - | - | - | -891,220 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -800,000 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -741,591 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -704,825 | -100.00% | - | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -700,000 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -549,469 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -542,971 | -100.00% | - | Jun 30, 2024 |
| MMCAP INTERNATIONAL INC. SPC | - | - | - | -451,433 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -445,197 | -100.00% | - | Jun 30, 2024 |
| SLOTNIK CAPITAL, LLC | - | - | - | -419,778 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -376,540 | -100.00% | - | Jun 30, 2024 |
| TIG ADVISORS, LLC | - | - | - | -333,988 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -307,541 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -282,303 | -100.00% | - | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | - | - | - | -267,871 | -100.00% | - | Jun 30, 2024 |
| WESTCHESTER CAPITAL MANAGEMENT, LLC | - | - | - | -257,368 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -231,434 | -100.00% | - | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | - | - | - | -201,948 | -100.00% | - | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | - | - | - | -190,389 | -100.00% | - | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | - | - | - | -145,966 | -100.00% | - | Jun 30, 2024 |
| CANTOR FITZGERALD, L. P. | - | - | - | -139,715 | -100.00% | - | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | - | - | - | -131,900 | -100.00% | - | Jun 30, 2024 |
| WETHERBY ASSET MANAGEMENT INC | - | - | - | -131,023 | -100.00% | - | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | - | - | - | -130,044 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -108,369 | -100.00% | - | Jun 30, 2024 |
| MERIDIAN WEALTH ADVISORS, LLC | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| AQR ARBITRAGE LLC | - | - | - | -97,774 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -82,829 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -78,400 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -72,764 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -65,287 | -100.00% | - | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | - | - | - | -56,173 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | - | - | - | -54,804 | -100.00% | - | Jun 30, 2024 |
| YAKIRA CAPITAL MANAGEMENT, INC. | - | - | - | -53,762 | -100.00% | - | Jun 30, 2024 |
| RHUMBLINE ADVISERS | - | - | - | -51,485 | -100.00% | - | Jun 30, 2024 |
| BIRCHVIEW CAPITAL, LP | - | - | - | -48,448 | -100.00% | - | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | - | - | - | -47,918 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -43,678 | -100.00% | - | Jun 30, 2024 |
| SWISS NATIONAL BANK | - | - | - | -42,000 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -40,976 | -100.00% | - | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -35,860 | -100.00% | - | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | - | - | - | -35,000 | -100.00% | - | Jun 30, 2024 |
| ALPS ADVISORS INC | - | - | - | -33,431 | -100.00% | - | Jun 30, 2024 |
| PROFUND ADVISORS LLC | - | - | - | -31,335 | -100.00% | - | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | - | - | - | -30,561 | -100.00% | - | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | - | - | - | -29,580 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -25,110 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -22,593 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -21,920 | -100.00% | - | Jun 30, 2024 |
| M&T BANK CORP | - | - | - | -21,476 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -20,765 | -100.00% | - | Jun 30, 2024 |
| ALAETHES WEALTH LLC | - | - | - | -19,341 | -100.00% | - | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -18,866 | -100.00% | - | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | - | - | - | -18,194 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -16,926 | -100.00% | - | Jun 30, 2024 |
| PROSHARE ADVISORS LLC | - | - | - | -16,741 | -100.00% | - | Jun 30, 2024 |
| FORA CAPITAL, LLC | - | - | - | -16,103 | -100.00% | - | Jun 30, 2024 |
| EQUITEC PROPRIETARY MARKETS, LLC | - | - | - | -16,000 | -100.00% | - | Jun 30, 2024 |
| BLACK MAPLE CAPITAL MANAGEMENT LP | - | - | - | -15,863 | -100.00% | - | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -14,812 | -100.00% | - | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | - | - | - | -14,673 | -100.00% | - | Jun 30, 2024 |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | - | - | - | -14,499 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -14,486 | -100.00% | - | Jun 30, 2024 |
| RS CRUM INC. | - | - | - | -14,119 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -13,882 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | - | - | - | -12,449 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -11,400 | -100.00% | - | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | - | - | - | -11,370 | -100.00% | - | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | - | - | - | -11,346 | -100.00% | - | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -10,982 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -10,218 | -100.00% | - | Jun 30, 2024 |
| FIFTH LANE CAPITAL, LP | - | - | - | -10,200 | -100.00% | - | Jun 30, 2024 |
| PARKWOOD LLC | - | - | - | -9,683 | -100.00% | - | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | - | - | - | -9,544 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -9,458 | -100.00% | - | Jun 30, 2024 |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | - | - | - | -9,106 | -100.00% | - | Jun 30, 2024 |
| SCIENTECH RESEARCH LLC | - | - | - | -8,240 | -100.00% | - | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | - | - | - | -8,143 | -100.00% | - | Jun 30, 2024 |
| GAM HOLDING AG | - | - | - | -8,000 | -100.00% | - | Jun 30, 2024 |
| HCR WEALTH ADVISORS | - | - | - | -6,300 | -100.00% | - | Jun 30, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | - | - | - | -5,848 | -100.00% | - | Jun 30, 2024 |
| CSS LLC/IL | - | - | - | -5,100 | -100.00% | - | Jun 30, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | - | - | - | -4,755 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -3,412 | -100.00% | - | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | - | - | - | -3,143 | -100.00% | - | Jun 30, 2024 |
| GREAT WEST LIFE ASSURANCE CO /CAN/ | - | - | - | -2,910 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,950 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -1,759 | -100.00% | - | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -1,369 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -1,324 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -1,215 | -100.00% | - | Jun 30, 2024 |
Inhibrx Biosciences's largest sold out institutional shareholder by shares sold is VIKING GLOBAL INVESTORS LP, sold -7.15M shares, valued at -, as of undefined.
Inhibrx Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| HARTFORD HLS SERIES FUND II INC | 0.41% | 101,959 | - | - | Dec 31, 2023 |
| MERIDIAN FUND INC | 0.09% | 199,625 | -39,953 | -16.68% | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 22,765 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.03% | 256,500 | - | - | Jan 31, 2024 |
| ROYCE MICRO-CAP TRUST, INC. | 0.03% | 12,995 | - | - | Mar 31, 2024 |
| MERGER FUND | 0.02% | 198,509 | 198,509 | - | Mar 28, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.02% | 674,716 | - | - | Feb 29, 2024 |
| MERGER FUND VL | 0.02% | 2,449 | 2,449 | - | Mar 28, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.02% | 2,985 | - | - | Mar 28, 2024 |
| Virtus Event Opportunities Trust | 0.01% | 35,267 | 35,267 | - | Mar 28, 2024 |
| SMALLCAP WORLD FUND INC | 0.01% | 814,082 | - | - | Mar 31, 2024 |
| IndexIQ ETF Trust | 0.01% | 25,723 | - | - | Jan 31, 2024 |
| Humankind Benefit Corp | 0.01% | 235 | -64 | -21.40% | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 61,358 | -1,703 | -2.70% | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.01% | 84,100 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,039 | -252 | -4.76% | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.01% | 94,255 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 19,137 | 310 | 1.65% | Feb 29, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 12,022 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 813 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,516,417 | -346,696 | -18.61% | Mar 31, 2024 |
| BARON SELECT FUNDS | 0.00% | 30,000 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 35,737 | 35,737 | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 149,109 | - | - | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 15,259 | - | - | Aug 31, 2023 |
| SCHWAB CAPITAL TRUST | 0.00% | 93,006 | -1,169 | -1.24% | Jan 31, 2024 |
| ETFis Series Trust I | 0.00% | 2,980 | -698 | -18.98% | Jan 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 32,352 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,412 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 260,544 | 10,570 | 4.23% | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 29,270 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 10,520 | 4,445 | 73.17% | Mar 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 88,254 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 5,894 | - | - | Jan 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 247,351 | -50,851 | -17.05% | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 22,181 | -4,675 | -17.41% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 99,123 | 8,117 | 8.92% | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 52,700 | - | - | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 10,266 | -3,610 | -26.02% | Jan 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 29,392 | - | - | Mar 31, 2024 |
| Janus Detroit Street Trust | 0.00% | 77,803 | - | - | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 5,871 | -482 | -7.59% | Mar 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 2,200 | - | - | Mar 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 73,248 | - | - | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 35,290 | -9,881 | -21.87% | Jan 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 9,376 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 7,887 | 1,262 | 19.05% | Feb 29, 2024 |
| Global X Funds | 0.00% | 15,798 | 1,387 | 9.62% | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 11,346 | -2,753 | -19.53% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,594 | -130 | -7.54% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 7,177 | 175 | 2.50% | Mar 31, 2024 |
| Harbor ETF Trust | 0.00% | 1,313 | - | - | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 66,905 | -22,169 | -24.89% | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 140,612 | 19,499 | 16.10% | Feb 29, 2024 |
| LOOMIS SAYLES FUNDS II | 0.00% | 635,605 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 12,000 | 400 | 3.45% | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 1,683 | 1,683 | - | Mar 28, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 477 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 24,271 | -155 | -0.63% | Mar 28, 2024 |
| Trust for Advised Portfolios | 0.00% | 2,843 | - | - | Dec 31, 2023 |
| Victory Portfolios II | 0.00% | 7,045 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 6,941 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,526 | 224 | 17.20% | Mar 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 10,469 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 620 | - | - | Mar 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 434,026 | - | - | Mar 31, 2024 |
| JPMorgan Trust I | 0.00% | 116,634 | - | - | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 1,526,285 | -70,023 | -4.39% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 155,892 | 18,853 | 13.76% | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 91,934 | -3,129 | -3.29% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 312 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 313 | - | - | Dec 31, 2023 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 7,716 | -18,371 | -70.42% | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 15,817 | 8,591 | 118.89% | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 332 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 13,180 | -53 | -0.40% | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 1,682,592 | 761,421 | 82.66% | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 3,873 | 1,121 | 40.73% | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 5,247 | - | - | Mar 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 17,685 | 4,232 | 31.46% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 155 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 1,100 | -100 | -8.33% | Mar 28, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 4,500 | 100 | 2.27% | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 3,583 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 3,991 | -1,816 | -31.27% | Jan 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 6,092 | - | - | Feb 29, 2024 |
| FLEXSHARES TRUST | 0.00% | 1,992 | 1,479 | 288.30% | Jan 31, 2024 |
| MAINSTAY FUNDS TRUST | 0.00% | 5,196 | 5,196 | - | Jan 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 9,723 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 66,804 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 4,753 | 1,106 | 30.33% | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 2,161 | - | - | Feb 29, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 5,573 | - | - | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 20 | - | - | Dec 31, 2023 |
| SPDR INDEX SHARES FUNDS | 0.00% | 2,907 | 165 | 6.02% | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 15,231 | - | - | Mar 31, 2024 |
| AMERICAN FUNDS INSURANCE SERIES | 0.00% | 98,278 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 11,523 | -129,057 | -91.80% | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,253 | - | - | Feb 29, 2024 |
| Pacer Funds Trust | 0.00% | 564 | -430 | -43.26% | Jan 31, 2024 |
Inhibrx Biosciences's largest mutual fund holder by % of total assets is "HARTFORD HLS SERIES FUND II INC", owning 101.96K shares, compromising 0.41% of its total assets.
Inhibrx Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 1 | -99.24% |
| 31 Mar, 24 | 131 | -2.96% |
| 31 Dec, 23 | 135 | 21.62% |
| 30 Sep, 23 | 111 | 1.83% |
| 30 Jun, 23 | 109 | -0.91% |
| 31 Mar, 23 | 110 | -8.33% |
| 31 Dec, 22 | 120 | 13.21% |
| 30 Sep, 22 | 106 | 8.16% |
| 30 Jun, 22 | 98 | -1.01% |
| 31 Mar, 22 | 99 | -2.94% |
| 31 Dec, 21 | 102 | 54.55% |
| 30 Sep, 21 | 66 | 8.20% |
| 30 Jun, 21 | 61 | 10.91% |
| 31 Mar, 21 | 55 | 7.84% |
| 31 Dec, 20 | 51 | 59.38% |
| 30 Sep, 20 | 32 | - |
As of 30 Jun 24, 1 institutions are holding Inhibrx Biosciences's shares, representing a decrease of -99.24% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 26,400 | -99.93% |
| 31 Mar, 24 | 38,256,224 | -5.67% |
| 31 Dec, 23 | 40,555,710 | 3.94% |
| 30 Sep, 23 | 39,019,167 | 8.34% |
| 30 Jun, 23 | 36,015,505 | -1.76% |
| 31 Mar, 23 | 36,661,959 | 1.68% |
| 31 Dec, 22 | 36,054,750 | 26.38% |
| 30 Sep, 22 | 28,529,569 | 9.04% |
| 30 Jun, 22 | 26,163,534 | 6.40% |
| 31 Mar, 22 | 24,589,313 | 5.79% |
| 31 Dec, 21 | 23,243,686 | 13.65% |
| 30 Sep, 21 | 20,451,493 | 4.46% |
| 30 Jun, 21 | 19,577,732 | 20.41% |
| 31 Mar, 21 | 16,259,717 | 4.44% |
| 31 Dec, 20 | 15,567,803 | 12.62% |
| 30 Sep, 20 | 13,823,443 | - |
Inhibrx Biosciences (INBX) has 26.40K shares outstanding as of 30 Jun 24, down -99.93% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 0.05% | 0.00% |
| 31 Mar, 24 | 81.17% | 1.10% |
| 31 Dec, 23 | 86.01% | 1.08% |
| 30 Sep, 23 | 89.41% | 1.31% |
| 30 Jun, 23 | 82.65% | 1.17% |
| 31 Mar, 23 | 84.14% | 1.04% |
| 31 Dec, 22 | 89.89% | 1.69% |
| 30 Sep, 22 | 73.02% | 1.63% |
| 30 Jun, 22 | 67.02% | 1.69% |
| 31 Mar, 22 | 63.02% | 1.74% |
| 31 Dec, 21 | 60.25% | 2.07% |
| 30 Sep, 21 | 53.97% | 2.01% |
| 30 Jun, 21 | 51.76% | 2.79% |
| 31 Mar, 21 | 43.09% | 2.53% |
| 31 Dec, 20 | 41.28% | 1.55% |
| 30 Sep, 20 | 51.68% | - |
As of 30 Jun 24, Inhibrx Biosciences is held by 0.05% institutional shareholders, representing a 0.00% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | - | -100.00% |
| 31 Mar, 24 | 66 | 6.45% |
| 31 Dec, 23 | 62 | 12.73% |
| 30 Sep, 23 | 55 | 1.85% |
| 30 Jun, 23 | 54 | 5.88% |
| 31 Mar, 23 | 51 | -31.08% |
| 31 Dec, 22 | 74 | 25.42% |
| 30 Sep, 22 | 59 | 1.72% |
| 30 Jun, 22 | 58 | 5.45% |
| 31 Mar, 22 | 55 | -12.70% |
| 31 Dec, 21 | 63 | 85.29% |
| 30 Sep, 21 | 34 | -19.05% |
| 30 Jun, 21 | 42 | 27.27% |
| 31 Mar, 21 | 33 | -15.38% |
| 31 Dec, 20 | 39 | 21.88% |
| 30 Sep, 20 | 32 | - |
- institutional shareholders have increased their position in INBX stock as of 30 Jun 24 compared to 66 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | - | -100.00% |
| 31 Mar, 24 | 38 | -11.63% |
| 31 Dec, 23 | 43 | 22.86% |
| 30 Sep, 23 | 35 | 12.90% |
| 30 Jun, 23 | 31 | -13.89% |
| 31 Mar, 23 | 36 | 12.50% |
| 31 Dec, 22 | 32 | 14.29% |
| 30 Sep, 22 | 28 | 21.74% |
| 30 Jun, 22 | 23 | -14.81% |
| 31 Mar, 22 | 27 | 12.50% |
| 31 Dec, 21 | 24 | 33.33% |
| 30 Sep, 21 | 18 | 125.00% |
| 30 Jun, 21 | 8 | -33.33% |
| 31 Mar, 21 | 12 | 71.43% |
| 31 Dec, 20 | 7 | - |
| 30 Sep, 20 | - | - |
- institutional shareholders have reduced their position in INBX stock as of 30 Jun 24 compared to 38 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 1 | -99.24% | 26,400 | -99.93% | 0.05% | 0.00% | - | -100.00% | - | -100.00% |
| 31 Mar, 24 | 131 | -2.96% | 38,256,224 | -5.67% | 81.17% | 1.10% | 66 | 6.45% | 38 | -11.63% |
| 31 Dec, 23 | 135 | 21.62% | 40,555,710 | 3.94% | 86.01% | 1.08% | 62 | 12.73% | 43 | 22.86% |
| 30 Sep, 23 | 111 | 1.83% | 39,019,167 | 8.34% | 89.41% | 1.31% | 55 | 1.85% | 35 | 12.90% |
| 30 Jun, 23 | 109 | -0.91% | 36,015,505 | -1.76% | 82.65% | 1.17% | 54 | 5.88% | 31 | -13.89% |
| 31 Mar, 23 | 110 | -8.33% | 36,661,959 | 1.68% | 84.14% | 1.04% | 51 | -31.08% | 36 | 12.50% |
| 31 Dec, 22 | 120 | 13.21% | 36,054,750 | 26.38% | 89.89% | 1.69% | 74 | 25.42% | 32 | 14.29% |
| 30 Sep, 22 | 106 | 8.16% | 28,529,569 | 9.04% | 73.02% | 1.63% | 59 | 1.72% | 28 | 21.74% |
| 30 Jun, 22 | 98 | -1.01% | 26,163,534 | 6.40% | 67.02% | 1.69% | 58 | 5.45% | 23 | -14.81% |
| 31 Mar, 22 | 99 | -2.94% | 24,589,313 | 5.79% | 63.02% | 1.74% | 55 | -12.70% | 27 | 12.50% |
| 31 Dec, 21 | 102 | 54.55% | 23,243,686 | 13.65% | 60.25% | 2.07% | 63 | 85.29% | 24 | 33.33% |
| 30 Sep, 21 | 66 | 8.20% | 20,451,493 | 4.46% | 53.97% | 2.01% | 34 | -19.05% | 18 | 125.00% |
| 30 Jun, 21 | 61 | 10.91% | 19,577,732 | 20.41% | 51.76% | 2.79% | 42 | 27.27% | 8 | -33.33% |
| 31 Mar, 21 | 55 | 7.84% | 16,259,717 | 4.44% | 43.09% | 2.53% | 33 | -15.38% | 12 | 71.43% |
| 31 Dec, 20 | 51 | 59.38% | 15,567,803 | 12.62% | 41.28% | 1.55% | 39 | 21.88% | 7 | - |
| 30 Sep, 20 | 32 | - | 13,823,443 | - | 51.68% | - | 32 | - | - | - |
Inhibrx Biosciences Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Inhibrx Biosciences's stock was made by VIKING GLOBAL INVESTORS LP on Jun 03 2024, selling 1,038,765 shares at - per share (valued at $103.88).
Inhibrx Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 33 | - |
| Q1 2024 | - | 18 | - |
| Q3 2023 | 2 | - | - |
| Q2 2023 | 4 | - | - |
| Q1 2023 | 3 | 17 | 17.65% |
| Q4 2022 | 2 | 38 | 5.26% |
| Q3 2022 | 2 | 12 | 16.67% |
| Q2 2022 | 8 | 2 | 400.00% |
| Q1 2022 | 1 | - | - |
| Q4 2021 | 1 | - | - |
| Q2 2021 | 3 | - | - |
| Q1 2021 | 4 | 4 | 100.00% |
| Q4 2020 | 2 | 2 | 100.00% |
| Q3 2020 | 8 | 10 | 80.00% |
0 total buy trades, and 33 total sell trades (buy/sell ratio of 0.00%) were made by Inhibrx Biosciences's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 1 | - |
| Q1 2024 | - | - | - |
| Q3 2023 | 2 | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | 17 | - |
| Q4 2022 | 2 | 38 | 5.26% |
| Q3 2022 | - | 8 | - |
| Q2 2022 | - | 2 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | 4 | - |
| Q4 2020 | - | - | - |
| Q3 2020 | 5 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Inhibrx Biosciences's stocks.
Inhibrx Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| DICE | DICE Therapeutics, Inc. |
| VRDN | Viridian Therapeutics, Inc. |
| IKNA | Ikena Oncology, Inc. |
| MRUS | Merus N.V. |
| LRMR | Larimar Therapeutics, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| LYEL | Lyell Immunopharma, Inc. |
| KRON | Kronos Bio, Inc. |
| CRNX | Crinetics Pharmaceuticals, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| PTGX | Protagonist Therapeutics, Inc. |
| CELC | Celcuity Inc. |
| MACK | Merrimack Pharmaceuticals, Inc. |
| OPT | Opthea Limited |
| ELVN | Enliven Therapeutics, Inc. |
| ELYM | Eliem Therapeutics, Inc. |
INBX Ownership FAQ
Who Owns Inhibrx Biosciences?
Inhibrx Biosciences is owned by institutional shareholders (0.05%), insiders (23.55%), and public (76.41%). The largest institutional shareholder of Inhibrx Biosciences is DEKABANK DEUTSCHE GIROZENTRALE (0.05% of total shares) and the top mutual fund owner is HARTFORD HLS SERIES FUND II INC (0.41% of total shares).
Who are the major institutional shareholders of Inhibrx Biosciences?
Inhibrx Biosciences's major institutional shareholders are DEKABANK DEUTSCHE GIROZENTRALE, ADVISOR GROUP HOLDINGS, INC., AMERICAN INTERNATIONAL GROUP, INC., JPMORGAN CHASE & CO, and US BANCORP \DE\. The top five shareholders own together 0.06% of the company's share outstanding.
How many Inhibrx Biosciences shareholders are there?
As of Jun 2024, there are 1 institutional shareholders of Inhibrx Biosciences.
What percentage of Inhibrx Biosciences is owned by DEKABANK DEUTSCHE GIROZENTRALE?
DEKABANK DEUTSCHE GIROZENTRALE owns 26.4K shares of Inhibrx Biosciences, representing 0.05% of the company's total shares outstanding, valued at $928K (as of Jun 2024).
What percentage of Inhibrx Biosciences is owned by ADVISOR GROUP HOLDINGS, INC?
As of Jun 2024, ADVISOR GROUP HOLDINGS, INC holds 6.69K shares of Inhibrx Biosciences (INBX), compromising 0.01% of the company, valued at $228.19K.
What percentage of Inhibrx Biosciences is owned by AMERICAN INTERNATIONAL GROUP, INC?
AMERICAN INTERNATIONAL GROUP, INC is the third largest holder of Inhibrx Biosciences. The company owns 0 of the company's shares outstanding (worth $0).